Do you consent to this website placing cookies on your device? You can find out more by reading our cookies policy.
Urenco ChemPlants owns and will operate our most recent nuclear new build, Urenco’s Tails Management Facility.
Urenco ChemPlants Read moreOur online annual sustainability report highlights our achievements in delivering for a net zero world.
Read it hereOur robust response to a changing market drives strong cash generation and increased order book.
Read our latest reportDiversity and inclusion is a high priority as we want to create a workforce that reflects the society in which we operate.
Gender Pay Gap Report Read moreUrenco Group (“Urenco” or “the Group”), an international supplier of uranium enrichment services and nuclear fuel cycle products, today announces its results for the half year ended 30 June 2021.
Read more Half Year 2021 Unaudited Financial ResultsSolid operational and financial performance despite COVID-19 pandemic, results slightly ahead of expectations London – 11 March 2021 – Urenco Group (&ldquo...
Read more Full Year 2020 Audited Financial ResultsLatest tweets
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries
Sign up to our newsletter by entering your email address below.